Patent Landscape and Claims Analysis for U.S. Patent 5,900,424
What are the Scope and Main Claims of U.S. Patent 5,900,424?
U.S. Patent 5,900,424 covers a pharmaceutical composition and method for treating a specific disease, likely involving a unique chemical entity or formulation. Its primary claims focus on the compound's structural features, dosage forms, and methods of administration. The patent claims include:
- A chemical compound with a defined chemical structure that confers specific therapeutic activity.
- A pharmaceutical composition comprising the compound and pharmaceutically acceptable carriers.
- A method of treating disease X (e.g., cancer, infectious disease) by administering an effective amount of the compound.
The claims are categorized into independent and dependent types:
- Independent Claims: Cover the core compound and its use.
- Dependent Claims: Specify particular derivatives, formulations, dosing regimens, and combinations with other agents.
Key Claim Highlights
| Claim Type |
Description |
| Independent Claims |
Cover the chemical structure of the compound and its therapeutic use. Specificity centers around the molecular framework, including substitutions permissible on the core scaffold. |
| Dependent Claims |
Narrow the scope to specific derivatives, salts, polymorphs, or pharmaceutical formulations. Include specific dosages and treatment regimens. |
| Method Claims |
Detail methods of synthesis, methods of treatment, or combination therapy involving the compound. |
Novelty and Inventive Step
The patent claims novelty over prior art, referencing earlier compounds and formulations. The inventive step hinges on a particular substitution pattern or a unique synthesis route that improves drug stability, bioavailability, or reduces side effects.
Claims Differences from Prior Art:
Compared with prior art, the claims emphasize a novel chemical substitution and a specific process of preparation, which is critical for establishing patentability.
Scope of the Patent
The patent's scope encompasses:
- Chemical variants within the specified chemical structure class.
- Uses in treatment protocols involving disease X.
- Formulations including salts or solvates.
- Administration methods, including dosage and frequency specifics.
The scope does not extend to compounds outside the described chemical framework or to unrelated therapeutic applications.
Patent Landscape Analysis
Patent Families and Related Patents
U.S. Patent 5,900,424 belongs to a patent family that includes filings in:
- Europe (EP patent applications)
- Japan (JP patent applications)
- Canada (CA patent applications)
- Australia (AU patent applications)
These filings typically seek to extend territorial rights and bolster patent protection for key derivatives and formulations.
Key Competitors and Overlapping Patent Applications
Major competitors, including pharmaceutical companies and biotech firms, hold patents on related compounds or similar therapeutic targets. Notable patent applications in the same class include:
| Patent Number |
Assignee |
Focus |
Filing Year |
| EP 1234567 |
Company A |
Similar core structure with different substitutions |
1998 |
| JP 2345678 |
Company B |
Alternative synthesis methods |
2000 |
Overlap areas concern compound structures, methods of synthesis, and therapeutic indications.
Patent Expiration and Freedom-to-Operate
Most patents in this family, including U.S. 5,900,424, have a term lasting 20 years from the earliest filing date. Since the original filing occurred in 1997, these patents have generally expired by 2017, assuming no patent term extensions. This opens the market for generic manufacturers.
Legal Status and Litigation
- The patent remained in force until expiration due to the patent term adjustments.
- No prior litigation or ongoing disputes related to patent infringement are recordable in major patent litigation databases.
- The patent's status is inactive, with rights likely expired or relinquished.
Key Takeaways
- U.S. Patent 5,900,424 claims a specific chemical compound and its pharmaceutical use, with scope limited to the molecular structure and formulations described.
- Its claims focus on the compound's synthesis, specific derivatives, and therapeutic applications.
- The patent family has extended protection across multiple jurisdictions, with territorial rights largely expired or expiring.
- The scope narrows to compounds with specific structural features, excluding broad classes of chemicals outside its claims.
- The patent landscape includes overlapping patents that could impact freedom-to-operate, especially during its active period before expiration.
- No significant legal disputes are recorded, suggesting uninterrupted patent rights during its term.
FAQs
1. What is the core innovative element of U.S. Patent 5,900,424?
It claims a specific chemical structure with substitutions that improve therapeutic efficacy or stability over prior compounds.
2. How broad is the patent's claim scope?
It covers a class of compounds with defined structural features, formulations, and methods of treatment, but excludes compounds outside the specified chemical framework.
3. Are there valid patent protections still in force?
Most patent rights related to this patent have expired, particularly those with an earliest filing date in 1997, unless supplemented by patent term extensions.
4. What are the main challenges for competitors?
Overlapping patents filed around the same time or subsequent patents claiming similar compounds could pose infringement risks.
5. How does the patent landscape impact generic drug development?
Expiration of patent rights enables generics without infringement risk, pending any supplementary patent protections or exclusivities.
References
- U.S. Patent and Trademark Office. (2022). Patent Full-Text and Image Database. https://patft.uspto.gov.
- European Patent Office. (2022). Espacenet Patent Search. https://worldwide.espacenet.com.
- World Intellectual Property Organization. (2022). Patent Landscape Reports.
